By Josh White
Date: Friday 17 Feb 2023
(Sharecast News) - Trellus Health announced the launch of a direct-to-consumer (D2C) offering for people living with Irritable Bowel Syndrome (IBS) on Friday.
By Josh White
Date: Tuesday 20 Dec 2022
(Sharecast News) - Trellus Health said in an update on Tuesday that for the 2022 period, it was expecting to report that "modest" revenue and an EBITDA loss in line with expectations.
By Josh White
Date: Wednesday 19 Oct 2022
(Sharecast News) - Trellus Health announced on Wednesday that the 'Trellus Resilience Training and Self-Management Solution' for inflammatory bowel disease was now available on GI OnDemand, a gastroenterology-focussed multidisciplinary virtual integrated care platform.
Currency | UK Pounds |
Share Price | 6.25p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 22.50 |
52 Week Low | 6.00 |
Volume | 49,386 |
Shares Issued | 161.51m |
Market Cap | £10.09m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
14:37 | 22,443 @ 6.17p |
14:37 | 22,443 @ 6.00p |
11:28 | 4,500 @ 6.49p |
You are here: research